Tag: clinical trials

RACT for Decentralized and Hybrid Trial Designs

Posted on By digi

RACT for Decentralized and Hybrid Trial Designs RACT for Decentralized and Hybrid Trial Designs The clinical research landscape is evolving, especially with the rapid adoption of decentralized and hybrid trial designs. The introduction of the Risk Assessment Categorization Tool (RACT) provides a structured method for evaluating risks associated with clinical trials. In this comprehensive guide,…

Read More “RACT for Decentralized and Hybrid Trial Designs” »

Risk Assessment Categorization Tool (RACT)

Inspection Case Studies: When Weak RACT Drove Serious Quality Issues

Posted on By digi

Inspection Case Studies: When Weak RACT Drove Serious Quality Issues Inspection Case Studies: When Weak RACT Drove Serious Quality Issues In the rapidly evolving landscape of clinical trials, adhering to regulatory requirements and standards of quality becomes paramount. The advent of risk-based monitoring (RBM) and remote oversight has introduced new methodologies and tools, such as…

Read More “Inspection Case Studies: When Weak RACT Drove Serious Quality Issues” »

Risk Assessment Categorization Tool (RACT)

Metrics and KPIs to Measure DMP Execution and Data Quality Outcomes

Posted on By digi

Metrics and KPIs to Measure DMP Execution and Data Quality Outcomes Metrics and KPIs to Measure DMP Execution and Data Quality Outcomes The purpose of this article is to provide regulatory and clinical research professionals with a comprehensive guide on how to effectively measure the execution of a Data Management Plan (DMP) and assess data…

Read More “Metrics and KPIs to Measure DMP Execution and Data Quality Outcomes” »

Data Management Plan (DMP)

Common DMP Pitfalls That Lead to Costly Rework and Delays

Posted on By digi

Common DMP Pitfalls That Lead to Costly Rework and Delays Common DMP Pitfalls That Lead to Costly Rework and Delays In the ever-evolving landscape of clinical research, the significance of a comprehensive Data Management Plan (DMP) cannot be overstated. As clinical operations, regulatory affairs, and medical affairs professionals, recognizing the common pitfalls associated with DMPs…

Read More “Common DMP Pitfalls That Lead to Costly Rework and Delays” »

Data Management Plan (DMP)

Adaptive Sample Size Re-Estimation: Methods, Risks and Regulatory Views

Posted on By digi

Adaptive Sample Size Re-Estimation: Methods, Risks and Regulatory Views Adaptive sample size re-estimation has become an increasingly prominent strategy in the conduct of clinical trials, particularly in the realms of gilead clinical trials and other adaptive trial designs. This comprehensive guide will provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…

Read More “Adaptive Sample Size Re-Estimation: Methods, Risks and Regulatory Views” »

Sample Size & Power Calculations

Linking RACT to CtQ Factors, QTLs and Vendor Oversight

Posted on By digi

Linking RACT to CtQ Factors, QTLs and Vendor Oversight In the evolving landscape of clinical trials, optimizing oversight mechanisms is imperative for ensuring compliance and data integrity. This step-by-step guide focuses on the Risk Assessment Categorization Tool (RACT), its correlation with Critical to Quality (CtQ) factors, Quality Tolerance Limits (QTLs), and the significance of vendor…

Read More “Linking RACT to CtQ Factors, QTLs and Vendor Oversight” »

Risk Assessment Categorization Tool (RACT)

Refreshing RACT Throughout the Study Lifecycle: When and How

Posted on By digi

Refreshing RACT Throughout the Study Lifecycle: When and How The Risk Assessment Categorization Tool (RACT) plays a crucial role in enhancing clinical trial oversight through effective risk-based monitoring (RBM). Addressing the need for a structured approach to risk assessments, RACT is an essential tool for clinical operations, regulatory affairs, and medical affairs professionals engaged in…

Read More “Refreshing RACT Throughout the Study Lifecycle: When and How” »

Risk Assessment Categorization Tool (RACT)

Using the DMP to Coordinate EDC, Coding, Safety and Biomarker Data Streams

Posted on By digi

Using the DMP to Coordinate EDC, Coding, Safety and Biomarker Data Streams Using the Data Management Plan (DMP) to Coordinate EDC, Coding, Safety, and Biomarker Data Streams A comprehensive Data Management Plan (DMP) is essential in the conduct of clinical trials, facilitating the effective integration of various data streams. This tutorial guide will provide a…

Read More “Using the DMP to Coordinate EDC, Coding, Safety and Biomarker Data Streams” »

Data Management Plan (DMP)

Regulatory Expectations for DMP Content in US, EU and UK Submissions

Posted on By digi

Regulatory Expectations for DMP Content in US, EU and UK Submissions Regulatory Expectations for DMP Content in US, EU and UK Submissions In the realm of clinical trials, ensuring data integrity and compliance with regulatory standards is of utmost importance. One critical component of achieving this goal is the Data Management Plan (DMP). This guide…

Read More “Regulatory Expectations for DMP Content in US, EU and UK Submissions” »

Data Management Plan (DMP)

Sample Size Considerations for Time-to-Event and Survival Endpoints

Posted on By digi

Sample Size Considerations for Time-to-Event and Survival Endpoints Sample Size Considerations for Time-to-Event and Survival Endpoints In the realm of clinical trials, especially those that focus on time-to-event and survival endpoints, determining the appropriate sample size is crucial to ensure the validity and reliability of study findings. This step-by-step guide aims to provide clinical operations,…

Read More “Sample Size Considerations for Time-to-Event and Survival Endpoints” »

Sample Size & Power Calculations